Madopar is available in over 80 countries worldwide, and is an oral formulation of levodopa and the decarboxylase inhibitor benserazide. It is used to treat patients with Parkinson's disease and restless leg syndrome (RLS).

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

you go to an external page